ChiCTR1900027183: Evaluation of the efficacy and safety of injection of rotigotine sustained-release microspheres in the treatment of patients with early-stage primary Parkinson's disease: a multicenter, randomized, double-blind, placebo-controlled study |
|
|
| Not yet recruiting | 3 | 294 | | LY03003 ;placebo | Xuanwu Hospital Capital Medical University; Shandong Luye Pharmaceutical Co., Ltd, Sponsor Supplied | Early primary Parkinson's disease | | | | |